R. Dar

Definitive radiation therapy management for medically non-resectable clinically localised non-small cell lung cancer: results & prognostic factors

L. Stitt, R. Malthaner, G. Rodrigues, 2007 .

Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22

K. Ding, M. Brundage, A. Fairchild, 2016, Supportive Care in Cancer.

What are the factors that predict outcome at relapse after previous esophagectomy and adjuvant therapy in high-risk esophageal cancer?

L. Stitt, B. Yaremko, R. Malthaner, 2010, Current oncology.

Postoperative extended-volume external-beam radiation therapy in high-risk esophageal cancer patients: a prospective experience

L. Stitt, B. Yaremko, R. Malthaner, 2009, Current oncology.

Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?

L. Stitt, R. Malthaner, G. Rodrigues, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma

R. Malthaner, M. Vincent, R. Inculet, 2001, Cancer.

Improving the consistency in cervical esophageal target volume definition by special training.

Jake Van Dyk, James Brierley, Edward Yu, 2002, International journal of radiation oncology, biology, physics.

Analysis of a novel protocol of combined induction chemotherapy and concurrent chemoradiation in unresected non-small-cell lung cancer: a ten-year experience with vinblastine, Cisplatin, and radiation therapy.

L. Stitt, B. Yaremko, R. Malthaner, 2010, Clinical lung cancer.